FMC stock holds as Fresenius Medical Care reports steady 2025 progress

FMC stock is anchored by Fresenius Medical Care AG (ISIN DE0005785802), which reported 2025 revenue of EUR 19.45 billion, operating income of EUR 1.80 billion, and free cash flow of EUR 857 million. The company also said the 2025 adjusted net income margin reached 8.4%, while the dividend proposal stood at EUR 1.44 per share.

2025 revenue and cash flow

Fresenius Medical Care said 2025 revenue rose 3% on a comparable basis to EUR 19.45 billion, while operating income increased 21% to EUR 1.80 billion. Free cash flow reached EUR 857 million in 2025, up from EUR 719 million a year earlier, giving the company a clear year-on-year improvement in cash generation.

The margin development matters because the company paired higher revenue with faster operating income growth. Adjusted net income rose 9% to EUR 1.58 billion in 2025, which helps explain why profitability, not just sales, remains the core investor metric.

Margin recovery in numbers

The company said the 2025 adjusted EBIT margin improved to 9.2%, compared with 7.8% in 2024. Adjusted net income margin advanced to 8.4% in 2025, from 7.9% a year earlier, while the dividend proposal of EUR 1.44 per share followed the stronger annual result.

That combination of 3% comparable revenue growth and 21% operating income growth is the key comparison in the report. For investors, the spread between sales growth and profit growth is the signal that the cost and mix profile improved over the year.

Care Delivery and Care Enablement

Fresenius Medical Care split its business into Care Delivery and Care Enablement, with 2025 continuing to show the benefit of a more focused structure. Care Delivery remained the larger earnings driver, while Care Enablement provided the products and services that support dialysis operations across the group.

The 2025 numbers show why the product and service mix matters. When operating income grows faster than revenue, the product and service base is doing more of the heavy lifting than pure volume growth.

Closing level

FMC stock is listed in Frankfurt, and the company remained tied to its 2025 financial base after reporting EUR 19.45 billion in revenue, EUR 1.80 billion in operating income, and EUR 857 million in free cash flow. Those three figures define the current frame for the share, even without a fresh intraday market print in this article.